[go: up one dir, main page]

ES2161412T3 - Paquete de vacuna que comprende un recipiente con compuestos vacunales liofilizados. - Google Patents

Paquete de vacuna que comprende un recipiente con compuestos vacunales liofilizados.

Info

Publication number
ES2161412T3
ES2161412T3 ES97200647T ES97200647T ES2161412T3 ES 2161412 T3 ES2161412 T3 ES 2161412T3 ES 97200647 T ES97200647 T ES 97200647T ES 97200647 T ES97200647 T ES 97200647T ES 2161412 T3 ES2161412 T3 ES 2161412T3
Authority
ES
Spain
Prior art keywords
vaccine
container
liofilized
package including
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97200647T
Other languages
English (en)
Inventor
Antonius Theodorus Wilderbeek
Hans Almer Middelbeek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2161412T3 publication Critical patent/ES2161412T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN RECIPIENTE DE VACUNA QUE CONTIENE UNO O MAS COMPONENTES DE VACUNA LIOFILIZADOS. EL COMPONENTE O LOS COMPONENTES DE LA VACUNA ESTAN PRESENTES EN DOS O MAS CUERPOS LIOFILIZADOS, AL MENOS UNO DE ELLOS ES UNA LIOSFERA. ASIMISMO, LA INVENCION SE REFIERE A METODOS PARA LA PREPARACION DE DICHO RECIPIENTE DE VACUNA Y A UN ENVASE DE VACUNA QUE INCLUYE EL RECIPIENTE DE VACUNA.
ES97200647T 1996-03-07 1997-03-05 Paquete de vacuna que comprende un recipiente con compuestos vacunales liofilizados. Expired - Lifetime ES2161412T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96200621 1996-03-07

Publications (1)

Publication Number Publication Date
ES2161412T3 true ES2161412T3 (es) 2001-12-01

Family

ID=8223754

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97200647T Expired - Lifetime ES2161412T3 (es) 1996-03-07 1997-03-05 Paquete de vacuna que comprende un recipiente con compuestos vacunales liofilizados.

Country Status (19)

Country Link
US (2) US5897852A (es)
EP (1) EP0799613B1 (es)
JP (1) JP4293643B2 (es)
KR (1) KR100458370B1 (es)
CN (1) CN1133423C (es)
AT (1) ATE202925T1 (es)
AU (1) AU704629B2 (es)
CA (1) CA2198195C (es)
DE (1) DE69705569T2 (es)
DK (1) DK0799613T3 (es)
EG (1) EG23992A (es)
ES (1) ES2161412T3 (es)
GR (1) GR3036725T3 (es)
HU (1) HU220532B1 (es)
IL (1) IL120202A (es)
NZ (1) NZ314267A (es)
PT (1) PT799613E (es)
SA (1) SA97170715B1 (es)
ZA (1) ZA971734B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
JP5209160B2 (ja) * 1999-08-24 2013-06-12 エービーアイシー・バイオロジカル・ラボラトリーズ・リミテッド ワクチン組成物およびその使用方法
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof
US6780581B2 (en) 2001-09-12 2004-08-24 Btf Pty Ltd Products comprising quantum of bioparticles and method for production thereof
RU2006126051A (ru) * 2003-12-19 2008-01-27 Альк-Абелло А/С (Dk) Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
TWI436789B (zh) 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
JP5689687B2 (ja) * 2008-03-05 2015-03-25 サノフィ・パスツールＳａｎｏｆｉｐａｓｔｅｕｒ アジュバント含有ワクチン組成物の安定化方法
EP2143440A1 (fr) * 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
TW201043267A (en) 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
US20130287786A1 (en) 2010-12-29 2013-10-31 Theodorus Petrus Maria Schetters Canine babesiosis vaccine antigen
AR087811A1 (es) 2011-09-08 2014-04-16 Umc Utrecht Holding Bv Vacuna contra el staphylococcus aureus
US10183968B2 (en) 2011-10-31 2019-01-22 Merck Sharp & Dohme Corp. Methods of preparing lyophilized spherical-shaped pellets of biological materials
WO2017066134A1 (en) * 2015-10-16 2017-04-20 Merck Sharp & Dohme Corp. Processes for preparing formulations for gastrointestinal-targeted therapies
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114159555A (zh) * 2021-12-08 2022-03-11 江西赛基生物技术有限公司 抗原蛋白冻干小球及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
CA980249A (en) * 1971-09-03 1975-12-23 Anglis R. Briggs Preparation of lyophilized serum and plasma
US3857423A (en) * 1971-12-27 1974-12-31 W Ronca Topical medicament kit with interlocking components
US3893280A (en) * 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
US4351158A (en) * 1980-01-22 1982-09-28 American Home Products Corporation Method of producing multicomponent lyophilized product
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IL86180A (en) 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
JPH07116022B2 (ja) * 1989-04-18 1995-12-13 三共株式会社 凍結乾燥製剤の製法
JPH0739339B2 (ja) * 1989-05-01 1995-05-01 アルカーメス コントロールド セラピューティクス，インコーポレイテッド 生物活性を有する分子の小粒子の製造方法
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
CA2051092C (en) * 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
WO1994025005A1 (en) * 1993-04-28 1994-11-10 Akzo Nobel N.V. Lyospheres comprising gonadotropin
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components

Also Published As

Publication number Publication date
EG23992A (en) 2008-03-09
HU220532B1 (hu) 2002-03-28
KR970064584A (ko) 1997-10-13
HUP9700556A2 (en) 1997-12-29
ZA971734B (en) 1997-09-09
PT799613E (pt) 2001-12-28
MX9701726A (es) 1998-03-31
CA2198195C (en) 2005-10-25
ATE202925T1 (de) 2001-07-15
CA2198195A1 (en) 1997-09-07
EP0799613A1 (en) 1997-10-08
JP4293643B2 (ja) 2009-07-08
AU1514997A (en) 1997-09-11
SA97170715B1 (ar) 2006-10-11
DE69705569T2 (de) 2002-05-16
US6106836A (en) 2000-08-22
DK0799613T3 (da) 2001-10-22
AU704629B2 (en) 1999-04-29
EP0799613B1 (en) 2001-07-11
DE69705569D1 (de) 2001-08-16
HU9700556D0 (en) 1997-04-28
KR100458370B1 (ko) 2005-07-07
HUP9700556A3 (en) 2000-04-28
CN1133423C (zh) 2004-01-07
NZ314267A (en) 1998-01-26
GR3036725T3 (en) 2001-12-31
CN1163102A (zh) 1997-10-29
JPH1024090A (ja) 1998-01-27
IL120202A (en) 2001-03-19
IL120202A0 (en) 1997-06-10
US5897852A (en) 1999-04-27

Similar Documents

Publication Publication Date Title
ES2161412T3 (es) Paquete de vacuna que comprende un recipiente con compuestos vacunales liofilizados.
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
CR5749A (es) Compuestos con cianoacrilato,curables por radiacion
ES2179105T3 (es) Adyuvantes proteinicos.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2091001T3 (es) Capsula que contiene un componente susceptible de degradacion y un polimero compuesto.
ES2032356A1 (es) Cebo envenenado para la erradicacion de insectos nocivos.
MX9200762A (es) Derivados de indol, procedimiento para su reparacion y composicion que los contiene.
BRPI0015939B8 (pt) sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação
MX9202152A (es) Derivados del indol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2190535T3 (es) Composiciones de lectina y uso de las mismas.
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
MX9201642A (es) Derivados de amidino fenil alanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
MX9204237A (es) Nuevos derivados de ciclohexano y tetrahidropiran, procedimiento para su preparacion y composicion antifungal que los contiene.
HN1999000196A (es) Derivados de indol
ES2150461T3 (es) Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes.
PT952975E (pt) Compostos bi-aromaticos ligados por um radical hetero-etinileno e composicoes farmaceuticas e cosmeticas que os contem
GT199900062A (es) Preparados efervescentes.
ES2174297T3 (es) Nuevos derivados de piranosidos.
MX9401171A (es) Forma purificada de estreptograminas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
MX9700854A (es) Derivados de azabicicloheptano n-substituidos utiles como neurolepticos.
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 799613

Country of ref document: ES